Milestone Achieved: 2,000 Surgeries with SSi Mantra
SS Innovations International, Inc. (OTC: SSII), a leader in surgical robotics, is thrilled to announce a major milestone: the successful completion of over 2,000 robotic surgeries using the SSi Mantra Surgical Robotic System. This achievement highlights the company's dedication to making advanced surgical technologies both accessible and affordable.
Bridging Disparities in Healthcare Access
Completing 2,000 surgeries is more than just a number; it’s a crucial response to ongoing healthcare challenges worldwide. As disparities in medical services continue, SS Innovations has shown its commitment to providing innovative surgical solutions that reach a wide variety of populations. The company's vision of 'democratizing access' and 'decentralizing excellence' emphasizes its goal of offering world-class healthcare to everyone, regardless of their financial background.
Impact of SSi Mantra in Surgical Settings
The SSi Mantra Surgical Robotic System has made a significant impact across many medical centers. Surgeons praise its user-friendly design and precise operations, which streamline minimally invasive procedures and enhance recovery experiences for patients. By reducing recovery times and complications, the SSi Mantra has become an essential tool in surgical settings, especially in areas where advanced healthcare technology is often less accessible.
Additionally, the SSi Mantra has made its mark in numerous Tier 2 and Tier 3 cities, allowing local communities to benefit from state-of-the-art surgical technology. Notably, it also stands out as Nepal's first surgical robot, significantly advancing healthcare capabilities in that region.
Versatility and Complexity of Procedures
The 2,000 surgeries cover a broad range of complexities, including 123 cardiac surgeries that demonstrate the system's versatility in managing various intricate surgical tasks. This flexibility is crucial for meeting diverse patient needs and effectively tackling complex health issues.
Leadership Vision and Commitment
In light of this significant achievement, Dr. Sudhir Srivastava, Founder, Chairman, and CEO of SS Innovations, expressed heartfelt appreciation for the hard work of the team. He stated, “The spirit of our engineers, their commitment to excellence, and their relentless pursuit to improve lives are what fuel our progress.”
Dr. Vishwa Srivastava, President and COO, added, “As a digital healthcare provider, our goal is to enhance global access to the latest surgical technologies. Celebrating this milestone reinforces the impact of our innovations and drives us to continue improving surgical outcomes everywhere.”
Future Endeavors and Global Expansion
The success of the SSi Mantra Surgical Robotic System in India has generated impressive quality and safety data, highlighting patient-focused clinical outcomes. This data will not only support SS Innovations' mission to enhance global healthcare but also be crucial as the company seeks regulatory approvals in new markets.
About SS Innovations International, Inc.
SS Innovations International, Inc. (OTC: SSII) is focused on developing innovative surgical robotic technologies aimed at increasing access to robotic surgery worldwide. Its offerings include the SSi Mantra surgical robotic system and the SSi Mudra platform of surgical instruments tailored for various procedures, including robotic cardiac surgery. With plans to expand its global presence, SSII strives to deliver advanced, user-friendly, and cost-effective solutions to healthcare providers around the globe.
About the SSi Mantra Surgical Robotic System
The SSi Mantra enhances surgical precision with its multi-specialty capabilities, supporting fields like cardiothoracic, gynecology, and urology, among others. Featuring a modular arm setup and advanced 3D 4K visualization, the system improves collaboration between surgeons and surgical teams, ensuring greater procedural safety and efficiency. Currently approved in India, the SSi Mantra has been validated for over 80 surgical procedures. Additionally, SS Innovations is actively working towards FDA and CE Mark approvals, looking to expand into international markets soon.
Frequently Asked Questions
What is the significance of SS Innovations reaching 2000 surgeries?
Reaching 2000 surgeries signifies SS Innovations' commitment to improving accessibility to advanced surgical technologies and highlights the effectiveness of the SSi Mantra system.
How has the SSi Mantra impacted surgical procedures?
The SSi Mantra has positively influenced patient outcomes by facilitating minimally invasive surgeries, resulting in shorter recovery times and fewer complications.
Where has the SSi Mantra been implemented?
The system is primarily used in India, particularly in Tier 2 and Tier 3 cities, and it has also been recognized as Nepal's first surgical robot.
What types of surgeries can the SSi Mantra perform?
The system is capable of handling a variety of specialties, including cardiothoracic, gynecology, and urology, showcasing its versatility in dealing with complex health issues.
What future plans does SS Innovations have for its robotic systems?
SS Innovations aims to broaden its market reach internationally while seeking regulatory approvals in regions such as the United States and the European Union.
